Altimmune, Inc. (ALT) — Financial statements
Income statement, balance sheet, and cash flow for Altimmune, Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 0.04↑105.0% | 0.02↓95.3% | 0.43↑726.5% | -0.07↓101.5% | 4 | |
| Cost of Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Gross Profit | 0.04↑105.0% | 0.02↓95.3% | 0.43↑726.5% | -0.07↓101.5% | 4 | |
| Operating Expenses | ||||||
| R&D Expenses | 66↓19.2% | 82↑25.0% | 66↓6.7% | 71↓5.4% | 75 | |
| General & Administrative Expenses | 28↑34.0% | 21↑15.6% | 18↑5.9% | 17↑11.2% | 15 | |
| Selling & Marketing Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SG&A Expenses | 28↑34.0% | 21↑15.6% | 18↑5.9% | 17↑11.2% | 15 | |
| Other Expenses | 0.00 | 0.00↓100.0% | 12 | 0.00↓100.0% | 11 | |
| Operating Expenses | 95↓8.4% | 103↑7.1% | 96↑9.9% | 88↓13.5% | 101 | |
| Total Costs & Expenses | 95↓8.4% | 103↑7.1% | 96↑9.9% | 88↓13.5% | 101 | |
| Operating Results | ||||||
| Operating Income | -94↑8.4% | -103↓7.6% | -96↓9.3% | -88↑9.5% | -97 | |
| Depreciation & Amortization | 0.11↓52.9% | 0.24↓50.1% | 0.48↓3.2% | 0.49↓10.5% | 0.55 | |
| EBITDA | -87↑8.2% | -95↓7.8% | -88↓4.2% | -84↑12.6% | -97 | |
| EBIT | -87↑8.3% | -95↓7.5% | -88↓4.1% | -85↑12.5% | -97 | |
| Interest & Other Income | ||||||
| Net Interest Income | 6↓26.8% | 8↑10.2% | 7↑155.6% | 3↑1345.5% | 0.20 | |
| Interest Income | 8↓6.6% | 8↑9.8% | 7↑156.1% | 3↑1313.8% | 0.20 | |
| Interest Expense | 2↑18077.8% | 0.01↓74.3% | 0.04↑337.5% | 0.01↑60.0% | 0.01 | |
| Non-Operating Income | -7↑9.5% | -8↓8.0% | -8↓164.9% | -3↓1759.6% | 0.17 | |
| Other Income / Expenses | 6↓29.6% | 8↑8.4% | 7↑164.4% | 3↑1708.0% | -0.18 | |
| Income Before Tax | -89↑6.6% | -95↓7.5% | -88↓4.2% | -85↑12.5% | -97 | |
| Income Tax Expense | -0.68 | 0.00 | 0.00↑100.0% | -0.20 | 0.00 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | -88↑7.3% | -95↓7.5% | -88↓4.4% | -85↑12.7% | -97 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | -88↑7.3% | -95↓7.5% | -88↓4.4% | -85↑12.7% | -97 | |
| Bottom-Line Net Income | -88↑7.3% | -95↓7.5% | -88↓4.4% | -85↑12.7% | -97 | |
| EPS (Basic) | -1.00↑25.4% | -1.34↑19.3% | -1.66↑8.3% | -1.81↑23.0% | -2.35 | |
| EPS (Diluted) | -1.00↑25.4% | -1.34↑19.3% | -1.66↑8.3% | -1.81↑23.0% | -2.35 | |
| Weighted Average Shares | 88↑24.1% | 71↑33.3% | 53↑13.5% | 47↑13.7% | 41 | |
| Weighted Average Diluted Shares | 88↑24.1% | 71↑33.3% | 53↑13.5% | 47↑13.7% | 41 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.